1. Home
  2. CGEN vs QSG Comparison

CGEN vs QSG Comparison

Compare CGEN & QSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • QSG
  • Stock Information
  • Founded
  • CGEN 1993
  • QSG 2019
  • Country
  • CGEN Israel
  • QSG China
  • Employees
  • CGEN N/A
  • QSG N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • QSG Other Consumer Services
  • Sector
  • CGEN Health Care
  • QSG Real Estate
  • Exchange
  • CGEN Nasdaq
  • QSG Nasdaq
  • Market Cap
  • CGEN 117.8M
  • QSG 140.0M
  • IPO Year
  • CGEN 2000
  • QSG 2023
  • Fundamental
  • Price
  • CGEN $1.47
  • QSG $6.20
  • Analyst Decision
  • CGEN Strong Buy
  • QSG
  • Analyst Count
  • CGEN 1
  • QSG 0
  • Target Price
  • CGEN $4.00
  • QSG N/A
  • AVG Volume (30 Days)
  • CGEN 216.5K
  • QSG 453.0K
  • Earning Date
  • CGEN 05-19-2025
  • QSG 06-09-2025
  • Dividend Yield
  • CGEN N/A
  • QSG 3.24%
  • EPS Growth
  • CGEN N/A
  • QSG 101.59
  • EPS
  • CGEN N/A
  • QSG 1.04
  • Revenue
  • CGEN $27,589,000.00
  • QSG $477,141,565.00
  • Revenue This Year
  • CGEN $11.81
  • QSG N/A
  • Revenue Next Year
  • CGEN $28.37
  • QSG $6.09
  • P/E Ratio
  • CGEN N/A
  • QSG $5.98
  • Revenue Growth
  • CGEN N/A
  • QSG N/A
  • 52 Week Low
  • CGEN $1.13
  • QSG $1.47
  • 52 Week High
  • CGEN $2.66
  • QSG $8.04
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 53.98
  • QSG 48.96
  • Support Level
  • CGEN $1.38
  • QSG $6.22
  • Resistance Level
  • CGEN $1.56
  • QSG $7.30
  • Average True Range (ATR)
  • CGEN 0.08
  • QSG 0.57
  • MACD
  • CGEN 0.02
  • QSG -0.21
  • Stochastic Oscillator
  • CGEN 68.97
  • QSG 18.56

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.

Share on Social Networks: